CA2980495C - Agents se liant specifiquement au motif rgd de la cadherine 17 humaine, de la cadherine 5 humaine, de la cadherine 6 humaine et de la cadherine 20 humaine - Google Patents

Agents se liant specifiquement au motif rgd de la cadherine 17 humaine, de la cadherine 5 humaine, de la cadherine 6 humaine et de la cadherine 20 humaine

Info

Publication number
CA2980495C
CA2980495C CA2980495A CA2980495A CA2980495C CA 2980495 C CA2980495 C CA 2980495C CA 2980495 A CA2980495 A CA 2980495A CA 2980495 A CA2980495 A CA 2980495A CA 2980495 C CA2980495 C CA 2980495C
Authority
CA
Canada
Prior art keywords
cdh17
seq
cancer
agent
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2980495A
Other languages
English (en)
Other versions
CA2980495A1 (fr
Inventor
Jose Ignacio Casal Alvarez
Ruben Alvaro Bartolome Conde
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority claimed from PCT/EP2015/058527 external-priority patent/WO2016169581A1/fr
Publication of CA2980495A1 publication Critical patent/CA2980495A1/fr
Application granted granted Critical
Publication of CA2980495C publication Critical patent/CA2980495C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des agents se liant spécifiquement à la cadhérine 17 humaine (CDH17), et/ou à la cadhérine 5 humaine (CDH5), et/ou à la cadhérine 6 humaine (CDH6), et/ou à la cadhérine 20 humaine (CDH20). L'invention concerne également l'utilisation de ces agents en thérapie, des méthodes pour le diagnostic et/ou le pronostic et/ou la stratification d'un cancer chez un sujet, et des compositions pharmaceutiques contenant lesdits agents. L'invention concerne également des marqueurs de cancer et des marqueurs de métastase.
CA2980495A 2015-04-20 Agents se liant specifiquement au motif rgd de la cadherine 17 humaine, de la cadherine 5 humaine, de la cadherine 6 humaine et de la cadherine 20 humaine Active CA2980495C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2015/058527 WO2016169581A1 (fr) 2015-04-20 2015-04-20 Agents se liant spécifiquement au motif rgd de la cadhérine 17 humaine, de la cadhérine 5 humaine, de la cadhérine 6 humaine et de la cadhérine 20 humaine

Publications (2)

Publication Number Publication Date
CA2980495A1 CA2980495A1 (fr) 2016-10-27
CA2980495C true CA2980495C (fr) 2025-09-09

Family

ID=

Similar Documents

Publication Publication Date Title
JP2021535733A (ja) Ｉｌ−１１抗体
CN113226471A (zh) Il-11ra抗体
KR101695056B1 (ko) 카드헤린-11의 ec1 도메인을 표적으로 하는 인간화 항체 및 관련 조성물 및 방법
US11136411B2 (en) Method for the treatment or prevention of a disease related to vascular endothelial lipase by administering a humanized monoclonal antibody
AU2026200353A1 (en) Anti-chemokin like receptor 1 antibodies and their therapeutic applications
CN113015751A (zh) 一种融合蛋白及其用途
AU2015392603B2 (en) Agents binding specifically to human cadherin-17, human cadherin-5, human cadherin-6 and human cadherin-20 RGD motif
KR20230117183A (ko) 새로운 종양 인게이저 치료 약물의 개발 및 이의 용도
WO2024008960A1 (fr) Molécules de liaison à l'antigène cnx
CN109384845B (zh) 一种cd40单克隆抗体、其制备方法及其应用
KR20250152073A (ko) 항체, 항원 결합 단편 및 사용 방법
TW202515914A (zh) 與ｎｋｇ２ａ結合的抗體或抗原結合片段及其用途
CN104837867B (zh) 特异性结合tm4sf5蛋白的新型单克隆抗体及其应用
JP6159010B2 (ja) テトラスパニン８に対するハイブリドーマクローンおよびモノクローナル抗体
CN108290942A (zh) 与人及小鼠信号素3a交联的抗体及其用途
KR101854529B1 (ko) 인간 및 마우스 Ｓｅｍａ３Ａ에 교차결합하는 항체 및 그의 용도
WO2024140820A1 (fr) Anticorps anti-nkg2a et son utilisation
CA2980495C (fr) Agents se liant specifiquement au motif rgd de la cadherine 17 humaine, de la cadherine 5 humaine, de la cadherine 6 humaine et de la cadherine 20 humaine
JP2013013327A (ja) Ｍａｎｓｃ１蛋白質に結合し、抗癌活性を有する抗体
JP2024533616A (ja) 新規のＷｎｔアゴニスト抗体およびその治療的使用
CN120329439A (zh) 一种单克隆抗体及其应用
CN115572330A (zh) 一种特异性抗体及其制备方法和应用
CN121358780A (zh) 与lilrb1结合的抗体或抗原结合片段及其用途
HK40047979A (en) Fusion protein and use thereof